ARCHIVES

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

This article is from The Cancer Letter archive.

Vol. 02 No. 37 | September 10, 1976

Download PDF Visit The Full Archive

Related Articles

NCI To require Prompt Publication Of Data Affected By Falsification In Future Grants

April 8, 1994

Columbia Univ. Places cDNA Libraries In Public Domain

April 28, 1995

NCI Plans SBIR “Bridge” Award To Commercialize Technology.

April 11, 2008

Proteomics Used To Find Predictor Of Response In FAP

April 30, 2004

In Brief: St. Jude, Yale to Get Bristol-Myers Grants; Five Named for New Young Scientists Awards

May 6, 1988

Army Will Outspend NCI In Breast Cancer In FY93, But How To Apply For a Grant?

October 16, 1992